TTD | Drug: D0B5SF

Drug General Information
Drug ID	D0B5SF
Former ID	DNC010837
Drug Name	4-(2-(3,4-Dimethylphenylamino)ethyl)-1H-imidazole
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530846]
Structure		Download 2D MOL 3D MOL
Formula	C13H17N3
Canonical SMILES	CC1=C(C=C(C=C1)NCCC2=CN=CN2)C
InChI	1S/C13H17N3/c1-10-3-4-12(7-11(10)2)15-6-5-13-8-14-9-16-13/h3-4,7-9,15H,5-6H2,1-2H3,(H,14,16)
InChIKey	GHCPLWBMALOXTM-UHFFFAOYSA-N
PubChem Compound ID	46222044
Target and Pathway
Target(s)	Histamine H3 receptor	Target Info	Inhibitor	[530846]
KEGG Pathway	Neuroactive ligand-receptor interaction
Reactome	Histamine receptors
Reactome	G alpha (i) signalling events
WikiPathways	Monoamine Transport
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 530846	J Med Chem. 2010 May 13;53(9):3840-4.Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.
Ref 530846	J Med Chem. 2010 May 13;53(9):3840-4.Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information